Financial reports
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
9 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-Q
2021 Q2
Quarterly report
4 Aug 21
10-Q
2021 Q1
Quarterly report
5 May 21
10-K
2020 FY
Annual report
10 Mar 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
6 Aug 20
10-Q
2020 Q1
Quarterly report
7 May 20
Current reports
8-K
Termination of a Material Definitive Agreement
17 Aug 22
8-K
Blueknight Announces Second Quarter 2022 Results
3 Aug 22
8-K
Regulation FD Disclosure
29 Jul 22
8-K
Blueknight Declares Quarterly Distributions and Announces Timing of Second Quarter 2022 Results
26 Jul 22
8-K
Blueknight Announces First Quarter 2022 Results
4 May 22
8-K
Regulation FD Disclosure
3 May 22
8-K
Blueknight Declares Quarterly Distributions and Announces Timing of First Quarter 2022 Results
26 Apr 22
8-K
Blueknight to be Acquired by its General Partner, Ergon
22 Apr 22
8-K
Blueknight Announces Fourth Quarter and Full Year 2021 Results
8 Mar 22
8-K
Blueknight Increases Quarterly Distribution
26 Jan 22
Registration and prospectus
15-12G
Securities registration termination
29 Aug 22
25-NSE
Exchange delisting
17 Aug 22
25-NSE
Exchange delisting
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 22
SC 13E3/A
Going private transaction (amended)
17 Aug 22
SC 13E3/A
Going private transaction (amended)
7 Jul 22
Proxies
DEFA14A
Additional proxy soliciting materials
29 Jul 22
DEFM14A
Proxy related to merger
7 Jul 22
PRER14A
Preliminary revised proxy
1 Jul 22
PREM14A
Preliminary proxy related to merger
1 Jun 22
DEFA14A
Additional proxy soliciting materials
3 May 22
DEFA14A
Additional proxy soliciting materials
22 Apr 22
DEF 14A
Definitive proxy
9 Oct 20
DEF 14C
Information statement
12 Sep 16
PRER14C
Preliminary revised information
9 Sep 16
PRER14C
Preliminary revised information
30 Aug 16
Other
CORRESP
Correspondence with SEC
1 Jul 22
UPLOAD
Letter from SEC
24 Jun 22
CT ORDER
Confidential treatment order
2 May 19
CT ORDER
Confidential treatment order
16 Aug 18
CT ORDER
Confidential treatment order
2 May 18
EFFECT
Notice of effectiveness
14 Nov 17
CORRESP
Correspondence with SEC
8 Nov 17
UPLOAD
Letter from SEC
7 Nov 17
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
14 Mar 17
CT ORDER
Confidential treatment order
19 Jan 17